Evaluation of a novel hexavalent humanized anti-IGF-1R antibody and its bivalent parental IgG in diverse cancer cell lines.
A major mechanism of monoclonal antibodies that selectively target the insulin-like growth factor type 1 receptor (IGF-1R) to inhibit tumor growth is by downregulating the receptor, regardless whether they are capable (antagonistic) or incapable (agonistic) of blocking the binding of cognate ligands...
Main Authors: | Chien-Hsing Chang, Yang Wang, Preeti Trisal, Rongxiu Li, Diane L Rossi, Anju Nair, Pankaj Gupta, Michele Losman, Thomas M Cardillo, Edmund A Rossi, David M Goldenberg |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3432068?pdf=render |
Similar Items
-
The Development of Bispecific Hexavalent Antibodies as a Novel Class of DOCK-AND-LOCKTM (DNLTM) Complexes
by: Chien-Hsing Chang, et al.
Published: (2013-05-01) -
Bivalent antibody pliers inhibit β-tryptase by an allosteric mechanism dependent on the IgG hinge
by: Henry R. Maun, et al.
Published: (2020-12-01) -
Insight into the avidity–affinity relationship of the bivalent, pH-dependent interaction between IgG and FcRn
by: Johannes Reusch, et al.
Published: (2024-12-01) -
Evaluation of cysticercus-specific IgG (total and subclasses) and IgE antibody responses in cerebrospinal fluid samples from patients with neurocysticercosis showing intrathecal production of specific IgG antibodies
by: Lisandra Akemi Suzuki, et al. -
Interferon-λ1 linked to a stabilized dimer of Fab potently enhances both antitumor and antiviral activities in targeted cells.
by: Donglin Liu, et al.
Published: (2013-01-01)